O Kellner

546 total citations
14 papers, 394 citations indexed

About

O Kellner is a scholar working on Oncology, Genetics and Emergency Medicine. According to data from OpenAlex, O Kellner has authored 14 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Genetics and 5 papers in Emergency Medicine. Recurrent topics in O Kellner's work include Neutropenia and Cancer Infections (7 papers), Hematological disorders and diagnostics (5 papers) and Blood disorders and treatments (5 papers). O Kellner is often cited by papers focused on Neutropenia and Cancer Infections (7 papers), Hematological disorders and diagnostics (5 papers) and Blood disorders and treatments (5 papers). O Kellner collaborates with scholars based in Germany, United States and Austria. O Kellner's co-authors include Hans‐Joachim Schmoll, Oliver A. Cornely, Orhan Sezer, Xaver Schiel, Helmut Ostermann, Hartmut Link, Rolf Mahlberg, Wolfgang Kern, Axel Grothey and Martin Wilhelm and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Hematology and Clinical Lung Cancer.

In The Last Decade

O Kellner

14 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Kellner Germany 7 305 119 97 63 59 14 394
H.-J. Laws Germany 11 172 0.6× 123 1.0× 51 0.5× 49 0.8× 31 0.5× 20 429
Carmen Salgado Chile 12 353 1.2× 249 2.1× 186 1.9× 112 1.8× 53 0.9× 37 523
Juan Tordecilla Chile 12 368 1.2× 248 2.1× 194 2.0× 112 1.8× 54 0.9× 27 542
Francisca M. Marti United Kingdom 5 307 1.0× 76 0.6× 131 1.4× 23 0.4× 44 0.7× 20 371
Isabelle Tkaczewski United States 8 257 0.8× 136 1.1× 137 1.4× 67 1.1× 28 0.5× 9 406
Pamela Silva Chile 7 225 0.7× 133 1.1× 133 1.4× 45 0.7× 16 0.3× 13 325
Lynn K. Rosenlof United States 10 120 0.4× 100 0.8× 18 0.2× 36 0.6× 61 1.0× 17 360
Antonio Latella Argentina 9 190 0.6× 39 0.3× 82 0.8× 168 2.7× 46 0.8× 18 426
Alexandre Debrumetz France 5 119 0.4× 170 1.4× 44 0.5× 54 0.9× 44 0.7× 8 275
Angela Haßler Germany 8 60 0.2× 225 1.9× 14 0.1× 103 1.6× 12 0.2× 9 377

Countries citing papers authored by O Kellner

Since Specialization
Citations

This map shows the geographic impact of O Kellner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Kellner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Kellner more than expected).

Fields of papers citing papers by O Kellner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Kellner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Kellner. The network helps show where O Kellner may publish in the future.

Co-authorship network of co-authors of O Kellner

This figure shows the co-authorship network connecting the top 25 collaborators of O Kellner. A scholar is included among the top collaborators of O Kellner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Kellner. O Kellner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Nagel, S., O Kellner, Walburga Engel-Riedel, et al.. (2011). Addition of Darbepoetin Alfa to Dose-Dense Chemotherapy: Results From a Randomized Phase II Trial in Small-Cell Lung Cancer Patients Receiving Carboplatin Plus Etoposide. Clinical Lung Cancer. 12(1). 62–69. 12 indexed citations
2.
Jordan, Karin, O Kellner, Thomas Kegel, Hans‐Joachim Schmoll, & Axel Grothey. (2004). Phase II Trial of Capecitabine/Irinotecan and Capecitabine/Oxaliplatin in Advanced Gastrointestinal Cancers. Clinical Colorectal Cancer. 4(1). 46–50. 30 indexed citations
3.
4.
Buchheidt, Dieter, Angelika Böhme, Oliver A. Cornely, et al.. (2003). Diagnosis and treatment of documented infections in neutropenic patients. Annals of Hematology. 82(S2). S127–S132. 76 indexed citations
5.
Link, Hartmut, Oliver A. Cornely, K. H�ffken, et al.. (2003). Antimicrobial therapy of unexplained fever in neutropenic patients. Annals of Hematology. 82(0). S105–S117. 166 indexed citations
6.
Grothey, Axel, Kim Jordan, O Kellner, et al.. (2003). 295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial. European Journal of Cancer Supplements. 1(5). S90–S91. 52 indexed citations
7.
Buchheidt, Dieter, Angelika Böhme, Oliver A. Cornely, et al.. (2001). Dokumentierte Infektionen bei Neutropenie - Empfehlungen zu Diagnostik und Therapie. DMW - Deutsche Medizinische Wochenschrift. 126(39). 1085–1090. 2 indexed citations
8.
Buchheidt, Dieter, Angelika Böhme, Oliver A. Cornely, et al.. (2001). Documented infections with neutropenia: therapeutic and diagnostic recommendations. DMW - Deutsche Medizinische Wochenschrift. 126(39). 1085–1090. 2 indexed citations
9.
10.
Kellner, O, Wieland Voigt, U Schneyer, Wolfram C. M. Dempke, & Hans‐Joachim Schmoll. (2001). HCG induced hyperthyreosis in germ cell cancer.. PubMed. 20(6D). 5135–8. 8 indexed citations
11.
Fätkenheuer, Gerd, Dieter Buchheidt, H. G. Fuhr, et al.. (2001). Venenkatheter-assoziierte Infektionen bei Patienten mit Neutropenie. DMW - Deutsche Medizinische Wochenschrift. 126(4). 89–95. 1 indexed citations
12.
Dempke, Wolfram C. M., et al.. (2000). [Hemorrhagic diathesis as initial symptom of stomach carcinoma].. PubMed. 112(24). 1053–8. 3 indexed citations
13.
Link, Hartmut, Angelika Böhme, Oliver A. Cornely, et al.. (1999). [Antimicrobial therapy for fever of unknown origin in neutropenia. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology].. PubMed. 124 Suppl 1. S3–8. 5 indexed citations
14.
Kellner, O, et al.. (1999). [Glucose infusions--a possible effective therapeutic option in ifosfamide-induced encephalopathy].. PubMed. 124(37). 1086–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.-J. Laws Breakdown of academic impact, for papers by Carmen Salgado Breakdown of academic impact, for papers by Juan Tordecilla Breakdown of academic impact, for papers by Francisca M. Marti Breakdown of academic impact, for papers by Isabelle Tkaczewski Breakdown of academic impact, for papers by Pamela Silva Breakdown of academic impact, for papers by Lynn K. Rosenlof Breakdown of academic impact, for papers by Antonio Latella Breakdown of academic impact, for papers by Alexandre Debrumetz Breakdown of academic impact, for papers by Angela Haßler
Rankless by CCL
2026